Private Equity Conversations with Fexingo: PE Funds, Buyouts, and Long-Hold Investing

Episode 57 of Private Equity Conversations examines the rapid consolidation of physical therapy clinics across the United States. Lucas and Luna break down the economics behind PE roll-ups in outpatient rehab, using the specific case of Athletico Physical Therapy—acquired by AEA Investors in 2021 and then merged with U.S. Physical Therapy. They discuss why PT clinics are attractive targets (recurring revenue, aging demographics, low margin but stable cash flows), the typical playbook of buying regional chains and centralizing billing, and the tension between investor return expectations and patient care. The episode includes data on the $40 billion outpatient PT market and the rise of platforms like FYZICAL and ATI. Lucas also flags a potential regulatory shift: the FTC's increased scrutiny of serial acquisitions in healthcare. No hot takes—just the mechanics of a deal type that touches millions of patients.

#PrivateEquity #PhysicalTherapy #HealthcareRollups #Athletico #AEAInvestors #USPhysicalTherapy #FYZICAL #ATI #OutpatientRehab #Consolidation #FTC #Investing #Finance #BusinessPodcast #FexingoBusiness #PEBuyouts #LongHoldInvesting #Episode57

Keep every episode free: buymeacoffee.com/fexingo

Self-storage has quietly become one of the most consolidated real estate sectors in America. In this episode, Lucas and Luna break down why private equity firms like Blackstone and Public Storage have spent over $20 billion on self-storage acquisitions since 2020. They examine the economics of the roll-up strategy, including how operators are using dynamic pricing algorithms to raise rents on existing tenants. The hosts also discuss the risks: oversupply in certain markets and the tension between occupancy rates and rental growth. By the end, listeners will understand why self-storage has become a favorite asset class for PE funds looking for steady cash flows and low operating costs.

#PrivateEquity #SelfStorage #Blackstone #PublicStorage #ExtraSpaceStorage #RealEstate #RollUp #Consolidation #DynamicPricing #AlternativeInvestments #Business #Finance #FexingoBusiness #BusinessPodcast #LucasAndLuna #AssetClass #REIT #StorageWars

Keep every episode free: buymeacoffee.com/fexingo

Episode 55 of Private Equity Conversations with Fexingo. Lucas and Luna dive into the quiet roll-up of independent insurance agencies by private equity firms. They focus on the specific case of Acrisure, which grew from a small Michigan agency in 2005 to a $20 billion-plus brokerage through hundreds of acquisitions. The hosts break down the economics: why insurance agencies are sticky, cash-flow machines, and how PE uses a 'buy and build' strategy to consolidate a fragmented market. They also discuss the risks for agents and policyholders, including potential conflicts of interest and service quality. A concrete look at a massive, largely invisible consolidation trend.

#PrivateEquity #InsuranceAgencies #Acrisure #RollUp #BuyAndBuild #Finance #Business #FexingoBusiness #BusinessPodcast #InsuranceBroker #Consolidation #IndependentAgents #PEInvesting #MergersAndAcquisitions #InsuranceIndustry #CashFlow #StickyRevenue #Episode55

Keep every episode free: buymeacoffee.com/fexingo

Private equity has consolidated veterinary general practices, specialty hospitals, and even pet cremation. Now it's moving upstream into the diagnostic labs that process blood work, urinalysis, and imaging for those clinics. Lucas and Luna examine the acquisition of a mid-sized veterinary diagnostics company by a buyout firm, the economics of lab roll-ups, and what it means for independent vets and pet owners. They discuss the shift from in-house blood analyzers to centralized reference labs, the margins that attract PE, and the regulatory moat that makes lab companies sticky. Specific numbers: the veterinary diagnostics market is estimated at roughly $4 billion in the U.S. and growing at 8-10 percent annually. The hosts also take a brief, unscripted moment to talk about listener support that keeps the show ad-free.

#PrivateEquity #VeterinaryDiagnostics #PetCare #VetLabs #Buyouts #PEInvesting #HealthcareRollUps #VetIndustry #DiagnosticTesting #PetHealth #Consolidation #LabServices #Finance #Business #FexingoBusiness #BusinessPodcast #Podcast #Investing

Keep every episode free: buymeacoffee.com/fexingo

Luke and Luna explore the rapid consolidation of the eyelash extension and beauty salon industry by private equity firms. They focus on the roll-up strategy behind Amazing Lash Studio, which has grown from a single location to over 250 studios nationwide since its acquisition by private equity in 2015. The hosts break down the economics: how PE firms standardize operations, negotiate bulk supply deals for eyelash adhesive and synthetic lashes, and build a franchise model to scale. They discuss the tension between maintaining a personal service touch and achieving operational efficiency, and what this trend means for independent salon owners. Also, a quick note on how listener support keeps the show ad-free.

#PrivateEquity #BeautyIndustry #EyelashExtensions #AmazingLashStudio #RollUpStrategy #FranchiseModel #BusinessConsolidation #PEInvesting #SmallBusiness #ServiceIndustry #LashSalons #BeautySalons #ScalableOperations #LucasAndLuna #FexingoBusiness #Finance #Podcast #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Home health agencies are becoming a prime target for private equity. With the aging Baby Boomer generation and the shift toward value-based care, PE firms see a huge opportunity in consolidating a fragmented industry. In this episode, Lucas and Luna break down the economics: how firms like Bain Capital and The Vistria Group are rolling up agencies, the regulatory headwinds from Medicare reimbursement changes, and what this means for patients and workers. They discuss the specific case of LHC Group's acquisition by Optum and the ripple effects. If you've ever wondered who really runs the nurses and aides that show up at your grandparents' door, this episode explains the deal structures, the margin pressures, and the roll-up playbook. Tune in for a focused look at one of the fastest-growing corners of healthcare services.

#PrivateEquity #HomeHealth #Healthcare #Finance #Business #BabyBoomers #Medicare #ValueBasedCare #BainCapital #VistriaGroup #LHCGroup #Optum #RollUp #Consolidation #HealthcareInvesting #FexingoBusiness #BusinessPodcast #Podcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the rapid consolidation of independent pharmacies by private equity firms, focusing on the case of Clinical Partners, a mid-market PE firm that has acquired over 200 independent pharmacies across the Midwest since 2021. They break down the economics: independent pharmacies are stable cash-flow businesses with a median EBITDA margin of 15-18 percent, but they face unsustainable pressure from pharmacy benefit managers (PBMs). Lucas explains the 'buy-and-build' strategy where PE firms roll up multiple pharmacies to create negotiating power against PBMs like CVS Caremark and Express Scripts. Luna highlights the trade-offs: pharmacists lose clinical autonomy but gain back-office support and better contract terms. The episode also touches on looming regulatory changes, including the PBM Transparency Act of 2025, which could reshape the economics of the roll-up thesis. A must-hear for anyone interested in the intersection of healthcare and private equity.

#PrivateEquity #IndependentPharmacies #PharmacyConsolidation #ClinicalPartners #PBMs #BuyAndBuild #Midwest #PharmacyEconomics #EBITDA #HealthcareRollUps #PharmacyBenefitManagers #RegulatoryRisk #PBMTransparencyAct #BusinessStrategy #Finance #BusinessPodcast #FexingoBusiness #PEStrategies

Keep every episode free: buymeacoffee.com/fexingo

In this 50th episode of Private Equity Conversations with Fexingo, Lucas and Luna dive into one of the fastest-growing consolidation frontiers: dermatology. They break down how PE firms are aggregating single-provider skin clinics into multi-state platforms, the economics behind the roll-up strategy, and what it means for patients and referring physicians. With over $15 billion in dermatology deals since 2020, the space has attracted firms like Goldman Sachs Asset Management, Welsh Carson, and Shore Capital. The hosts explain the 'dermatologist shortage' narrative, the rise of medical spas and cosmetic cash-pay services, and the tension between clinical autonomy and corporate efficiency. Specific examples include the U.S. Dermatology Partners platform and the Advanced Dermatology and Cosmetic Surgery chain. The episode also touches on reimbursement tailwinds from an aging population and the increasing prevalence of skin cancer screenings. No hype, just the deal mechanics and market realities.

#PrivateEquity #Dermatology #HealthcareRollUps #PEInvesting #SkinCare #DermatologyPractice #HealthcareM&A #U.S.DermatologyPartners #AdvancedDermatology #GoldmanSachs #WelshCarson #ShoreCapital #MedicalSpa #CosmeticDermatology #AgingPopulation #SkinCancer #BusinessPodcast #FexingoBusiness

Keep every episode free: buymeacoffee.com/fexingo

Private equity has quietly become the dominant force in urgent care. In this episode, Lucas and Luna break down the economics: a single urgent care center can generate $2 million to $4 million in annual revenue with 20–25% EBITDA margins. They explore the classic roll-up playbook — with names like GoHealth, CityMD, and MedExpress — and discuss the tensions between clinical quality and financial engineering. Lucas explains the multiple arbitrage model: buy individual clinics at 6–8x EBITDA, combine them into a regional chain, and sell to a larger platform or insurer at 12–15x. Luna raises the patient experience question: does consolidation actually make care better or just more profitable? They also touch on the regulatory uncertainty around surprise billing and state-level corporate practice of medicine restrictions. If you've ever wondered why every strip mall seems to have yet another urgent care sign, this episode explains the private equity logic behind it.

#PrivateEquity #UrgentCare #HealthcareInvesting #RollUpStrategy #MultipleArbitrage #GoHealth #CityMD #MedExpress #EBITDA #Consolidation #HealthcareM&A #BusinessPodcast #FinancePodcast #Investing #PEInvesting #FexingoBusiness #Business #Healthcare

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Private Equity Conversations with Fexingo, Lucas and Luna examine the rapid roll-up of optometry and ophthalmology practices by private equity firms. The conversation centers on the economics of eyecare: why PE sees it as a durable, recession-resistant asset class with recurring revenue from frames, exams, and procedures like LASIK. Lucas breaks down the typical model—PE acquires a regional practice, centralizes back-office functions, then expands through add-on acquisitions—and highlights a real example: the rise of platforms like Vision Source and the consolidation of independent optometrists. Luna questions whether quality of care suffers as corporate owners push for higher patient volumes and retail sales of glasses. They also discuss regulatory pushback in states like California and Texas, where optometry boards have tried to limit corporate ownership. The episode closes by considering what this means for the average patient: more locations and longer hours, but perhaps less one-on-one time with the doctor. A don't-miss deep dive for anyone curious about where PE is placing its next big bets.

#PrivateEquity #Eyecare #Optometry #Ophthalmology #VisionSource #Luxottica #HealthcareRollUp #PEInvesting #Buyouts #Finance #Business #FexingoBusiness #BusinessPodcast #Consolidation #HealthcarePE #OpticalIndustry #LASIK #RegulatoryRisk

Keep every episode free: buymeacoffee.com/fexingo